-
srdr.ahrq.gov/projects/1520/studies/186815
January 01, 2018 - • Do the benefits and harms vary by patient characteristics, course of illness, or other factors?
-
srdr.ahrq.gov/projects/1312/studies/133132
January 01, 2008 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133144
January 01, 2001 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133157
January 01, 2012 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133176
January 01, 2007 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133164
January 01, 2013 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133260
January 01, 2015 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133272
January 01, 2008 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133255
January 01, 2009 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133308
January 01, 2015 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133355
January 01, 2013 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1520/studies/186135
January 01, 2012 - the effects and harms vary by patient characteristics, presentation or course of illness, or other factors … comparative) effects and harms vary by patient characteristics, presentation or course of illness, or other factors … the effects and harms vary by patient characteristics, presentation or course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186136
January 01, 2017 - the effects and harms vary by patient characteristics, presentation or course of illness, or other factors … comparative) effects and harms vary by patient characteristics, presentation or course of illness, or other factors … the effects and harms vary by patient characteristics, presentation or course of illness, or other factors
-
srdr.ahrq.gov/projects/1312/studies/133098
January 01, 2010 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133151
January 01, 2012 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133172
January 01, 2015 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133159
January 01, 2015 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133209
January 01, 2010 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133210
January 01, 2010 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/133213
January 01, 2011 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors